167 related articles for article (PubMed ID: 35339636)
1. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis.
Kitami K; Yoshihara M; Tamauchi S; Sugiyama M; Koya Y; Yamakita Y; Fujimoto H; Iyoshi S; Uno K; Mogi K; Ikeda Y; Yokoi A; Yoshikawa N; Nishino K; Niimi K; Nawa A; Enomoto A; Kajiyama H
Matrix Biol; 2022 May; 109():70-90. PubMed ID: 35339636
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
[TBL] [Abstract][Full Text] [Related]
3. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
4. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
Kenny HA; Chiang CY; White EA; Schryver EM; Habis M; Romero IL; Ladanyi A; Penicka CV; George J; Matlin K; Montag A; Wroblewski K; Yamada SD; Mazar AP; Bowtell D; Lengyel E
J Clin Invest; 2014 Oct; 124(10):4614-28. PubMed ID: 25202979
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination.
Mogi K; Yoshihara M; Iyoshi S; Kitami K; Uno K; Tano S; Koya Y; Sugiyama M; Yamakita Y; Nawa A; Tomita H; Kajiyama H
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802781
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
[TBL] [Abstract][Full Text] [Related]
7. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
Wilson RB; Archid R; Reymond MA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
[TBL] [Abstract][Full Text] [Related]
10. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
[TBL] [Abstract][Full Text] [Related]
12. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
13. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells.
Jiang CG; Lv L; Liu FR; Wang ZN; Na D; Li F; Li JB; Sun Z; Xu HM
Cytokine; 2013 Jan; 61(1):173-80. PubMed ID: 23073116
[TBL] [Abstract][Full Text] [Related]
15. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
[TBL] [Abstract][Full Text] [Related]
16. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
Lv ZD; Wang HB; Dong Q; Kong B; Li JG; Yang ZC; Qu HL; Cao WH; Xu HM
Mol Cell Biochem; 2013 May; 377(1-2):177-85. PubMed ID: 23392771
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
19. Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
Pascual-Antón L; Sandoval P; González-Mateo GT; Kopytina V; Tomero-Sanz H; Arriero-País EM; Jiménez-Heffernan JA; Fabre M; Egaña I; Ferrer C; Simón L; González-Cortijo L; Sainz de la Cuesta R; López-Cabrera M
J Pathol; 2023 Oct; 261(2):238-251. PubMed ID: 37555348
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]